BioCentury | Aug 8, 2020
Management Tracks

PacBio shifts executive team; plus changes at CMAB, Valo, Alentis, Amwell and more

...basis while the company searches for a successor. Gong was VP of finance. Biologics CDMO CMAB Biopharma (Suzhou) Inc....
...at the Dermira Inc. unit of Eli Lilly and Co. (NYSE:LLY). BioCentury Staff Pacific Biosciences of California Inc. CMAB Biopharma (Suzhou) Inc. Valo...
BioCentury | Apr 14, 2020
Management Tracks

Kelly joins CytoDyn as CMO amid COVID-19 trials; plus Antengene, Genetron, Bolt, BioSpecifics, CMAB and more

...U.S. Bio-Oncology medical affairs unit at the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY). CDMO CMAB Biopharma (Suzhou) Inc....
...affairs and finance, will become interim CFO. Robin Sawka, BioCentury Staff CytoDyn Inc. Antengene Corp. Bolt Biotherapeutics Inc. BioSpecifics Technologies Corp. CMAB Biopharma (Suzhou) Inc. Exicure...
BioCentury | Apr 11, 2020
Management Tracks

Harpal Kumar named president of Grail Europe; plus Notable, Oncoceutics, ReAlta, Parker Institute

...NASDAQ:GHDX). Robin Sawka, BioCentury Staff Grail Inc. Notable Labs Inc. Oncoceutics Inc. Parker Institute for Cancer Immunotherapy Bolt Biotherapeutics Inc. BioSpecifics Technologies Corp. CMAB Biopharma (Suzhou) Inc. Exicure...
BioCentury | Aug 22, 2019
Company News

Aug. 21 Company Quick Takes: GSK, FibroGen take regulatory steps forward for HIF-PH inhibitors in Asia; plus Xtandi, Biotheus/Alligator and more

...in February (see "HaiHe's Listing Recipe" ). CMAB to manufacture Kintor’s ACVRL1 antibody CDMO company CMAB Biopharma...
...Writers daprodustat (GSK1278863, 1278863) roxadustat (ASP1517, FG-4592) Xtandi, enzalutamide (mdv3100, p-INN) Alligator Bioscience AB Astellas Pharma Inc. AstraZeneca plc Chinese Academy of Sciences CMAB Biopharma FibroGen...
BioCentury | Apr 25, 2019
Finance

The academic founders' conundrum

...Ltd. Zhejiang, China $61.2 Advantech Capital , Green Pine Capital Partners Ph I Cancer 2011 CMAB Biopharma (Suzhou) Inc....
BioCentury | Apr 6, 2018
Financial News

CMAB raises $34M for manufacturing upgrade

...series A round in January (see BioCentury, Jan. 5 ). CMAB Biopharma Inc., Suzhou, China Elizabeth S. Eaton CMAB Biopharma (Suzhou) Inc....
BioCentury | Apr 2, 2018
Financial News

CMAB raises $34M for manufacturing upgrade

...$38 million in a series A round in January (see BioCentury, Jan. 19) . Elizabeth S. Eaton CMAB Biopharma (Suzhou) Inc....
BioCentury | Jan 19, 2018
Finance

Incubating in China

...companies from the ground up. Its two most recent investments -- Everest Medicines Ltd. and CMAB Biopharma...
...Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. China Food and Drug Administration (CFDA), Beijing, China CMAB Biopharma...
...to strike.” BioCentury (2017) McCallister, E. “Opening the gates in China.” BioCentury (2017) Stephen Hansen, Associate Editor CMAB Biopharma Everest...
BioCentury | Jan 5, 2018
Financial News

CMAB raises $38M series A

...the Suzhou Industrial Park Biotech Development Co. Ltd. (BioBay) innovation hub. CMAB Biopharma Inc., Suzhou, China Virginia Li CMAB Biopharma...
BioCentury | Jan 2, 2018
Financial News

CMAB raises $38M series A

...at the Suzhou Industrial Park Biotech Development Co. Ltd. (BioBay) innovation hub in Suzhou, China. Virginia Li CMAB Biopharma...
Items per page:
1 - 10 of 10
BioCentury | Aug 8, 2020
Management Tracks

PacBio shifts executive team; plus changes at CMAB, Valo, Alentis, Amwell and more

...basis while the company searches for a successor. Gong was VP of finance. Biologics CDMO CMAB Biopharma (Suzhou) Inc....
...at the Dermira Inc. unit of Eli Lilly and Co. (NYSE:LLY). BioCentury Staff Pacific Biosciences of California Inc. CMAB Biopharma (Suzhou) Inc. Valo...
BioCentury | Apr 14, 2020
Management Tracks

Kelly joins CytoDyn as CMO amid COVID-19 trials; plus Antengene, Genetron, Bolt, BioSpecifics, CMAB and more

...U.S. Bio-Oncology medical affairs unit at the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY). CDMO CMAB Biopharma (Suzhou) Inc....
...affairs and finance, will become interim CFO. Robin Sawka, BioCentury Staff CytoDyn Inc. Antengene Corp. Bolt Biotherapeutics Inc. BioSpecifics Technologies Corp. CMAB Biopharma (Suzhou) Inc. Exicure...
BioCentury | Apr 11, 2020
Management Tracks

Harpal Kumar named president of Grail Europe; plus Notable, Oncoceutics, ReAlta, Parker Institute

...NASDAQ:GHDX). Robin Sawka, BioCentury Staff Grail Inc. Notable Labs Inc. Oncoceutics Inc. Parker Institute for Cancer Immunotherapy Bolt Biotherapeutics Inc. BioSpecifics Technologies Corp. CMAB Biopharma (Suzhou) Inc. Exicure...
BioCentury | Aug 22, 2019
Company News

Aug. 21 Company Quick Takes: GSK, FibroGen take regulatory steps forward for HIF-PH inhibitors in Asia; plus Xtandi, Biotheus/Alligator and more

...in February (see "HaiHe's Listing Recipe" ). CMAB to manufacture Kintor’s ACVRL1 antibody CDMO company CMAB Biopharma...
...Writers daprodustat (GSK1278863, 1278863) roxadustat (ASP1517, FG-4592) Xtandi, enzalutamide (mdv3100, p-INN) Alligator Bioscience AB Astellas Pharma Inc. AstraZeneca plc Chinese Academy of Sciences CMAB Biopharma FibroGen...
BioCentury | Apr 25, 2019
Finance

The academic founders' conundrum

...Ltd. Zhejiang, China $61.2 Advantech Capital , Green Pine Capital Partners Ph I Cancer 2011 CMAB Biopharma (Suzhou) Inc....
BioCentury | Apr 6, 2018
Financial News

CMAB raises $34M for manufacturing upgrade

...series A round in January (see BioCentury, Jan. 5 ). CMAB Biopharma Inc., Suzhou, China Elizabeth S. Eaton CMAB Biopharma (Suzhou) Inc....
BioCentury | Apr 2, 2018
Financial News

CMAB raises $34M for manufacturing upgrade

...$38 million in a series A round in January (see BioCentury, Jan. 19) . Elizabeth S. Eaton CMAB Biopharma (Suzhou) Inc....
BioCentury | Jan 19, 2018
Finance

Incubating in China

...companies from the ground up. Its two most recent investments -- Everest Medicines Ltd. and CMAB Biopharma...
...Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. China Food and Drug Administration (CFDA), Beijing, China CMAB Biopharma...
...to strike.” BioCentury (2017) McCallister, E. “Opening the gates in China.” BioCentury (2017) Stephen Hansen, Associate Editor CMAB Biopharma Everest...
BioCentury | Jan 5, 2018
Financial News

CMAB raises $38M series A

...the Suzhou Industrial Park Biotech Development Co. Ltd. (BioBay) innovation hub. CMAB Biopharma Inc., Suzhou, China Virginia Li CMAB Biopharma...
BioCentury | Jan 2, 2018
Financial News

CMAB raises $38M series A

...at the Suzhou Industrial Park Biotech Development Co. Ltd. (BioBay) innovation hub in Suzhou, China. Virginia Li CMAB Biopharma...
Items per page:
1 - 10 of 10